Medicinal products with irinotecan 2026
Original notice title
LP s obsahem irinotekanu 2026
Opportunity Score
Why this score?
Opportunity
60 / 100
Complexity
40 / 100
Risk factors
Selection criteria not detailed in structured data; potentially strict qualification requirements.
Tie-breaking by lottery introduces uncertainty if price equal.
Submission deadline in 7 days
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications
Overview
Strong opportunityKey Facts
- CZK 6.5M estimated value
- Supplies contract
- 2 lots
- Duration 36 MONTH
- Recurring supply of irinotecan (antineoplastic agent) to Fakultní nemocnice Olomouc.
- Contract duration: 36 months.
Show full summary
Recurring supply of irinotecan (antineoplastic) to Fakultní nemocnice Olomouc over 36 months. Open procedure, two lots, price-only award. Estimated total value 6,473,820 CZK. Submission deadline 2026-07-01 08:00 CET.
Risks
Selection criteria not detailed in structured data; potentially strict qualification requirements.
Tie-breaking by lottery introduces uncertainty if price equal.
Submission deadline in 7 days
Analysis may be incomplete
Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.
Key Requirements
Technical
- Deadline: 2026-07-01 08:00 CET.
Administrative
- Electronic submission via Open portal
- Language: Czech (CES).
Requirements may be incomplete.
Award Criteria
Lot 1
Lot 2
Buyer
Name
Fakultní nemocnice Olomouc
Location
Olomouc - Nová Ulice, CZE
Website
Buyer profile
Identifier
00098892
Lots (2)
LOT-0001
IRINOTEKAN I.
Recurring deliveries of medicinal products with active substance irinotecan meeting SUKL requirements.
CZK 1.1M
Estimated value
Location
Duration
Category
Selection criteria
Deadline
Award details
Value note
Show original TED data
Original TED description
Předmětem této části veřejné zakázky jsou opakující se dodávky léčivých přípravků s účinnou látkou IRINOTEKAN splňujících požadavky SÚKL.
LOT-0002
IRINOTEKAN II.
Recurring deliveries of medicinal products with active substance irinotecan (part II).
CZK 5.4M
Estimated value
Location
Duration
Category
Selection criteria
Deadline
Award details
Value note
Show original TED data
Original TED description
Předmětem této části veřejné zakázky jsou opakující se dodávky léčivých přípravků s účinnou látkou IRINOTEKAN splňujících požadavky SÚKL.
Procurement Details
- Publication date
- 27 May 2026
- Notice type
- Contract notice — standard
- Languages
- Czech
Reference metadata
- Notice subtype
- 16
- Notice version
- 1
- Legal basis
- 32014L0024
Reference IDs
- Tender ID
- 366849-2026
- Source notice ID
- 029b70e2-6fcd-4ba5-aa65-75eafdaf3c83
Documents (1)
Similar tenders
Poland – Antineoplastic agents – Dostawa produktów leczniczych i wyrobów medycznych do Wojskowego Instytutu Medycznego – PIB
Romania – Antineoplastic agents – achizitia de medicamente utilizate in tratamentul pacientilor beneficiari ai Programului Programului national de oncologie-Subprogramul de tratament medicamentos al bolnavilor cu afectiuni oncologice (adulti si copii), Programul national de oncologie medicamente COST-VOLUM
Poland – Immunoglobulins – Dostawy produktów leczniczych, wyrobów medycznych oraz substancji do receptury
Poland – Medicinal products for the blood, blood-forming organs and the cardiovascular system – Dostawa produktów leczniczych dla krwi, organów krwiotwórczych oraz układu krążenia, toksyn, środków leczniczych dla układu oddechowego, środków przeciwnowotworowych i immunomodulacyjnych stosowanych w ramach programów lekowych i chemioterapii, immunoglobulin oraz środków antywirusowych do użytku ogólnoustrojowego dla SPWSZ w Szczecinie
Slovakia – Antineoplastic and immunomodulating agents – Antineoplastické a imunomodulačné činidlá ( bežné )
Poland – Antineoplastic and immunomodulating agents – DOSTAWA LEKÓW ONKOLOGICZNYCH DLA WOJEWÓDZKIEGO SZPITALA SPECJALISTYCZNEGO IM. NAJŚWIĘTSZEJ MARYI PANNY W CZĘSTOCHOWIE
Opportunity Score
Why this score?
Opportunity
60 / 100
Complexity
40 / 100
Risk factors
Selection criteria not detailed in structured data; potentially strict qualification requirements.
Tie-breaking by lottery introduces uncertainty if price equal.
Submission deadline in 7 days
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications